• 1
    Population Reference Bureau [homepage on the Internet]. Washington (DC) : PRB; 2004 [cited 2005 May 15]. Preventing Cervical Cancer Worldwide. Available from:
  • 2
    Sherris J, Herdman C, Elias C. Beyond our borders: Cervical cancer in the developing world. West J Med 2001;175(4):23135.
  • 3
    Hoffman M, Cooper D, Carrara H, Rosenberg L, et al. Limited pap screening associated with reduced risk of Cervical Cancer in South Africa. Int J Epidemiol 2003;32:5737.
  • 4
    Schiffman M, Castle PE. The Promise of Global Cervical-Cancer Prevention. N Engl J Med 2005;353(20):21014.
  • 5
    Yabroff KR, Lawrence WF, Mangan P, Washington KS, et al. Geographical disparities in Cervical Cancer mortality: what are the roles of risk factors prevalence, screening, and the use of recommended treatment? (Abstract). J Rural Health 2005;21(2):14957.
  • 6
    Bayo S, Boasch FX, De Sanjose S, Munoz N, et al. Risk factors of invasive Cervical Cancer. Int J Epidemiol 2002;31:2029.
  • 7
    Goldie SJ, Gaffikin L, Goldhaber-Fiebert JD, Gordillo-Tobar A, et al. Cost-effectiveness of cervical cancer screening in five developing countries. N Engl J Med 2005;353:215868.
  • 8
    Howe SL, Vargas DE, Granada D, Smith JK. Cervical cancer prevention in remote rural Nicaragua: A program evaluation. Gynecol Oncol 2005;99 Suppl 3:2325.
  • 9
    Chen CA, Heish CY. Recent advances and problems in primary therapy for cervical cancer in Taiwan. J Formos Med Assoc 2004;103(7): 5118.
  • 10
    Katz IT, Wright AA. Preventing cervical cancer in the developing world. N Engl J Med 2006;354(11):1110.
  • 11
    Sankaranarayanan R, Budukh AM, Rajkumar R. Effective screening programmes for cervical cancer in low- and middle-income developing countries. Bull World Health Organ 2001;79(10):95463.
  • 12
    Mandelblatt JS, Lawrence WF, Gaffikin L, Limpahayom KK. Costs and benefits to different strategies to screen for Cervical Cancer in less-developed countries J Natl Cancer Inst 2002;94(1):146985.
  • 13
    Suba EJ. Crossing the quality chasm: a requirement for successful cervical cancer prevention in developing countries. Clin Lab Med 2004;24:94563.
  • 14
    Wasti S, Ahmed W, Jafri A, Khan B, et al. Analysis of cervical smears in a Muslim population. Ann Saudi Med 2004;24(3):18992.
  • 15
    Denny L. The prevention of cervical cancer in developing countries. BJOG: an international journal of obstetrics and gynaecology 2005;112:120412.
  • 16
    New Zealand International Aid & Development Agency [homepage on the Internet]. Wellington (NZ) : NZAID; 2005 [cited 2006 May 1]. Vanuatu Overview. Available from:
  • 17
    Australian Business Volunteers [homepage on the Internet]. Canberra (AUST) : ABV; 2004 [cited 2006 May 1]. Republic of Vanuatu and Business Volunteers: A Country Strategy for the Period 2005-2010. Available from:
  • 18
    Vanuatu Statistics Office [homepage on the Internet]. Port Vila (VUT) : The Office; 2003 [cited on 2006 Oct 17]. Facts on Population of Vanuatu. Available from:
  • 19
    Country Health Information Profile 2006. Western Pacific Region Health Databank, 2006 Revision [cited on 2006 Nov 16]. Available from:
  • 20
    Ferlay J, Bray F, Pisani P, Parkin DM. GLOBOCAN 2000. Cancer Incidence, Mortality and Prevalence Worldwide. Version 1.0. Lyon (FRA): IARC Press; 2001 [cited 2006 May 1]. IARC Cancer Base No. 5. Available from:
  • 21
    Stewart JM. Cervical cytology study in Port Vila, Vanuatu. Venereology 1996;9(4):24953.
  • 22
    Huff BC. Abnormal cervical cytology in pregnancy: a laboratory and clinical dermatological perspective. J Perinat Neonatal Nurs 2000;14(1):5262.
  • 23
    Watkins RS, Moran WP. Competency-based learning: The impact of targeted resident education and feedback on Pap smear rates. J Gen Intern Med 2004;19(5):5458.
  • 24
    Naud P, Matos J, Hammes L, Prolla J, et al. Cervical cancer screening in Porto Alegro, Brazil: Alternative methods for detecting cancer precursors in a developing country. J Low Genit Tract Dis 2001;5(1):248.
  • 25
    Victorian Cervical Cytology Registry. Statistical Report 2005. VCCR, Carlton South , Victoria . Available from: http://vccr.or/downloads/stats%20report%202005.pdf [cited 2006 13 July].
  • 26
    Castellsague X, Munoz N. Chapter 3: Cofactors in human papillomavirus carcinogenesis – role of parity, oral contraceptive, and tobacco smoking. J Natl Cancer Inst Monogr 2003;31:208.
  • 27
    Chan PKS, Chang AR, Tam W, Cheung JLK, et al. Prevalence and genotype distribution of cervical human papillomavirus infection: comparison between pregnant women and non-pregnant controls. J Med Virol. 2002;167:5838.
  • 28
    Kahn JA. Vaccination as a prevention strategy for human papillomavirus-related disease. J Adolesc Health 2005;37 Suppl 6:106.
  • 29
    Franceschi S, Rajkumar T, Vaccarella S, Gajalakshmi V et al. Human papillomavirus and risk factors for cervical cancer in Chennai, India: a case-control study (Abstract). Int J Cancer 2003;107(1):12733.
  • 30
    Zhao F, Forman MR, Belinson J. Risk factors for HPV infection and Cervical Cancer among unscreened women in a high-risk rural area of China. Int J Cancer 2006;118(2):4428.
  • 31
    Mauad EC, Gomes UA, Nogueira JL, Melani AGF, et al. Prevention of cervical cancer in a poor population in Brazil. Fam Pract 2002;19:18992.
  • 32
    Wiwanitkit V. Screening for cervical cancer, results from Thailand. Asian Pac J Cancer Prev 2006;7(2):32930.
  • 33
    Hamad HMA. Cancer initiatives in Sudan. Ann Oncol. 2006;Suppl 8:326.
  • 34
    Basile S, Angioli R, Manci N, Palaia I, et al. Gynaecological cancers in developing countries: the challenges of chemotherapy in low-resource settings. Int J Gynecol Cancer 2006;16(4):14917.
  • 35
    Zeferino LC, Derchain SF. Cervical cancer in the developing world. Best Pract Res Clin Obstet Gynaecol 2006;20(3):33954.
  • 36
    Denny L, Quinn M, Sankaranarayanan R. Screening for cervical cancer in developing countries. Vaccine 2006;24 Suppl 3:717.